GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A<sub>2A</sub> Adenosine Receptor

By Anna Shiriaeva, Daejin Park, Gyudong Kim, Yoonji Lee, Xiyan Hou, Dnyandev B. Jarhad, Gibae Kim, Jinha Yu, Young Eum Hyun, Woomi Kim, Zhan-Guo Gao, Kenneth A. Jacobson, Gye Won Han, Raymond C. Stevens, Lak Shin Jeong, Sun Choi, Vadim Cherezov1

1. Bridge Institute - University of Southern California

See also

No results found.

Published on

Type

journal-article

Author

Anna Shiriaeva and Daejin Park and Gyudong Kim and Yoonji Lee and Xiyan Hou and Dnyandev B. Jarhad and Gibae Kim and Jinha Yu and Young Eum Hyun and Woomi Kim and Zhan-Guo Gao and Kenneth A. Jacobson and Gye Won Han and Raymond C. Stevens and Lak Shin Jeong and Sun Choi and Vadim Cherezov

Citation

Shiriaeva, A., Park, D., Kim, G., Lee, Y., Hou, X., Jarhad, D. B., Kim, G., Yu, J., Hyun, Y. E., Kim, W., Gao, Z.-G., Jacobson, K. A., Han, G. W., Stevens, R. C., Jeong, L. S., Choi, S., & Cherezov, V. (2022). GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A2A Adenosine Receptor. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c00462

DOI

Funding

NSF-STC Biology with X-ray Lasers (NSF-1231306)